chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: COVID-19; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021 and was forwarded to Moderna on 04-Mar-2021.    This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of COVID-19 (COVID-19) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 025J20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma (Serious asthma).   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, SARS-CoV-2 test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication included multiple medications for serious asthma.  Treatment medications were unknown.  The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable.  The patient reported that they want to check if there is information on a bad batch for the vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Added email address of the patient.; Reporter's Comments: Lack of Drug Efficacy.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy to vaccine, Breast pain, Breast tenderness, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: pain in the breast; breast is tender; allergic reaction to the second dose; itchiness, itchy on the arm; itchiness and redness on the arm and it's swollen and itchy; redness on the arm and said that it spread; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (pain in the breast), BREAST TENDERNESS (breast is tender), ALLERGY TO VACCINE (allergic reaction to the second dose), VACCINATION SITE PRURITUS (itchiness, itchy on the arm) and VACCINATION SITE SWELLING (itchiness and redness on the arm and it's swollen and itchy) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: flu shot (The patient had similar reaction as when it had the flu shot.). Concurrent medical conditions included Blood pressure abnormal.   On 30-Nov-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BREAST PAIN (pain in the breast), BREAST TENDERNESS (breast is tender), ALLERGY TO VACCINE (allergic reaction to the second dose), VACCINATION SITE PRURITUS (itchiness, itchy on the arm), VACCINATION SITE SWELLING (itchiness and redness on the arm and it's swollen and itchy) and VACCINATION SITE ERYTHEMA (redness on the arm and said that it spread). At the time of the report, BREAST PAIN (pain in the breast) and BREAST TENDERNESS (breast is tender) had not resolved and ALLERGY TO VACCINE (allergic reaction to the second dose), VACCINATION SITE PRURITUS (itchiness, itchy on the arm), VACCINATION SITE SWELLING (itchiness and redness on the arm and it's swollen and itchy) and VACCINATION SITE ERYTHEMA (redness on the arm and said that it spread) had resolved.            Concomitantly, patient was taking Triaminitron for blood pressure.  The patient did not take any treatment.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: pain in the breast; breast is tender; allergic reaction to the second dose; itchiness, itchy on the arm; itchiness and redness on the arm and it's swollen and itchy; redness on the arm and said that it spread; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (pain in the breast), BREAST TENDERNESS (breast is tender), ALLERGY TO VACCINE (allergic reaction to the second dose), VACCINATION SITE PRURITUS (itchiness, itchy on the arm) and VACCINATION SITE SWELLING (itchiness and redness on the arm and it's swollen and itchy) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: flu shot (The patient had similar reaction as when it had the flu shot.). Concurrent medical conditions included Blood pressure abnormal.   On 30-Nov-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BREAST PAIN (pain in the breast), BREAST TENDERNESS (breast is tender), ALLERGY TO VACCINE (allergic reaction to the second dose), VACCINATION SITE PRURITUS (itchiness, itchy on the arm), VACCINATION SITE SWELLING (itchiness and redness on the arm and it's swollen and itchy) and VACCINATION SITE ERYTHEMA (redness on the arm and said that it spread). At the time of the report, BREAST PAIN (pain in the breast) and BREAST TENDERNESS (breast is tender) had not resolved and ALLERGY TO VACCINE (allergic reaction to the second dose), VACCINATION SITE PRURITUS (itchiness, itchy on the arm), VACCINATION SITE SWELLING (itchiness and redness on the arm and it's swollen and itchy) and VACCINATION SITE ERYTHEMA (redness on the arm and said that it spread) had resolved.            Concomitantly, patient was taking Triaminitron for blood pressure.  The patient did not take any treatment.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: High fever 102.3F; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021. The most recent information was received on 30-Apr-2021 and was forwarded to Moderna on 11-May-2021.    This spontaneous case was reported by an other caregiver and describes the occurrence of PYREXIA (High fever 102.3F) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Had COVID around November and December).   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 03-Mar-2021, the patient experienced PYREXIA (High fever 102.3F). At the time of the report, PYREXIA (High fever 102.3F) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) dosing remained unchanged.       Concomitant product use was not provided  by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: action taken with drug updated
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: rash on her arms, torso, back, and a little on her legs and rash was very itchy; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (rash on her arms, torso, back, and a little on her legs and rash was very itchy) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No medical history was provided by the reporter. .  Concomitant products included ATORVASTATIN and FAMOTIDINE for an unknown indication.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced RASH PRURITIC (rash on her arms, torso, back, and a little on her legs and rash was very itchy). The patient was treated with PREDNISONE for Rash pruritic, at an unspecified dose and frequency and HYDROCORTISONE for Rash pruritic, at an unspecified dose and frequency. On 28-Jan-2021, RASH PRURITIC (rash on her arms, torso, back, and a little on her legs and rash was very itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Myalgia, Pyrexia
Clinical narrative: Body aches; Chills; Tired; low grade fever of 99.9; Diarrhea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021 and was forwarded to Moderna on 04-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), MYALGIA (Body aches), CHILLS (Chills), FATIGUE (Tired) and PYREXIA (low grade fever of 99.9) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced DIARRHOEA (Diarrhea). On an unknown date, the patient experienced MYALGIA (Body aches), CHILLS (Chills), FATIGUE (Tired) and PYREXIA (low grade fever of 99.9). On 04-Mar-2021, DIARRHOEA (Diarrhea) had resolved. At the time of the report, MYALGIA (Body aches), CHILLS (Chills), FATIGUE (Tired) and PYREXIA (low grade fever of 99.9) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Events updated.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Myalgia, Pyrexia
Clinical narrative: Fever 102.2°F; bad headache; Rush too in the site of injection; chills; body ache; throw up.; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever 102.2°F), HEADACHE (bad headache), VACCINATION SITE RASH (Rush too in the site of injection), CHILLS (chills) and MYALGIA (body ache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PYREXIA (Fever 102.2°F), HEADACHE (bad headache), VACCINATION SITE RASH (Rush too in the site of injection), CHILLS (chills), MYALGIA (body ache) and VOMITING (throw up.). On 11-Feb-2021, PYREXIA (Fever 102.2°F) had resolved. At the time of the report, HEADACHE (bad headache), VACCINATION SITE RASH (Rush too in the site of injection), CHILLS (chills), MYALGIA (body ache) and VOMITING (throw up.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Body temperature: 102.2 (High) 102.2°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.    Most recent FOLLOW-UP information incorporated above includes: On 30-Mar-2021: NNI; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash, Vomiting
Clinical narrative: Fever 102.2°F; bad headache; Rush too in the site of injection; chills; body ache; throw up.; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever 102.2°F), HEADACHE (bad headache), VACCINATION SITE RASH (Rush too in the site of injection), CHILLS (chills) and MYALGIA (body ache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PYREXIA (Fever 102.2°F), HEADACHE (bad headache), VACCINATION SITE RASH (Rush too in the site of injection), CHILLS (chills), MYALGIA (body ache) and VOMITING (throw up.). On 11-Feb-2021, PYREXIA (Fever 102.2°F) had resolved. At the time of the report, HEADACHE (bad headache), VACCINATION SITE RASH (Rush too in the site of injection), CHILLS (chills), MYALGIA (body ache) and VOMITING (throw up.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Body temperature: 102.2 (High) 102.2°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.    Most recent FOLLOW-UP information incorporated above includes: On 30-Mar-2021: NNI; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Body temperature, Diarrhoea, Illness, Pyrexia
Clinical narrative: sick and feverish; diarrhea; stomach crumps/ stomach issues; sick and feverish,99°F fever,the fever is unusual,fever of 101.6°F around 2 to 3 am; vomiting/ throwing up; This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (sick and feverish,99°F fever,the fever is unusual,fever of 101.6°F around 2 to 3 am), VOMITING (vomiting/ throwing up), ILLNESS (sick and feverish), DIARRHOEA (diarrhea) and ABDOMINAL PAIN UPPER (stomach crumps/ stomach issues) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03ML20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021 at 4:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced PYREXIA (sick and feverish,99°F fever,the fever is unusual,fever of 101.6°F around 2 to 3 am), ILLNESS (sick and feverish), DIARRHOEA (diarrhea) and ABDOMINAL PAIN UPPER (stomach crumps/ stomach issues). 10-Feb-2021, the patient experienced VOMITING (vomiting/ throwing up). The patient was treated with PARACETAMOL (TYLENOL) in February 2021 for Adverse event, at a dose of UNK dosage form. At the time of the report, PYREXIA (sick and feverish,99°F fever,the fever is unusual,fever of 101.6°F around 2 to 3 am), VOMITING (vomiting/ throwing up), ILLNESS (sick and feverish), DIARRHOEA (diarrhea) and ABDOMINAL PAIN UPPER (stomach crumps/ stomach issues) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Body temperature: 101.6 101.6 degree F. On 12-Feb-2021, Body temperature: 99 (High) 99 degree F 97 degree F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported. The patient took vaccine around 4 or 5 PM on 09-Feb-2021 and by 2or 3 AM the patient started experiencing the events. On 12-Feb-2021 the symptoms were the worst that 11-Feb-2021 but better than the other days. It was reported that Tylenol did help.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: sick and feverish; diarrhea; stomach crumps/ stomach issues; sick and feverish,99°F fever,the fever is unusual,fever of 101.6°F around 2 to 3 am; vomiting/ throwing up; This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (sick and feverish,99°F fever,the fever is unusual,fever of 101.6°F around 2 to 3 am), VOMITING (vomiting/ throwing up), ILLNESS (sick and feverish), DIARRHOEA (diarrhea) and ABDOMINAL PAIN UPPER (stomach crumps/ stomach issues) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03ML20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021 at 4:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced PYREXIA (sick and feverish,99°F fever,the fever is unusual,fever of 101.6°F around 2 to 3 am), ILLNESS (sick and feverish), DIARRHOEA (diarrhea) and ABDOMINAL PAIN UPPER (stomach crumps/ stomach issues). 10-Feb-2021, the patient experienced VOMITING (vomiting/ throwing up). The patient was treated with PARACETAMOL (TYLENOL) in February 2021 for Adverse event, at a dose of UNK dosage form. At the time of the report, PYREXIA (sick and feverish,99°F fever,the fever is unusual,fever of 101.6°F around 2 to 3 am), VOMITING (vomiting/ throwing up), ILLNESS (sick and feverish), DIARRHOEA (diarrhea) and ABDOMINAL PAIN UPPER (stomach crumps/ stomach issues) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Body temperature: 101.6 101.6 degree F. On 12-Feb-2021, Body temperature: 99 (High) 99 degree F 97 degree F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported. The patient took vaccine around 4 or 5 PM on 09-Feb-2021 and by 2or 3 AM the patient started experiencing the events. On 12-Feb-2021 the symptoms were the worst that 11-Feb-2021 but better than the other days. It was reported that Tylenol did help.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Peripheral swelling, Rash
Clinical narrative: swollen arm; red and itchy arm; Injection site pruritus; Injection site swelling; injectio site redness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021 and was forwarded to Moderna on 04-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm), RASH (red and itchy arm), INJECTION SITE PRURITUS (Injection site pruritus), INJECTION SITE SWELLING (Injection site swelling) and INJECTION SITE ERYTHEMA (injectio site redness) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 001M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced PERIPHERAL SWELLING (swollen arm), RASH (red and itchy arm), INJECTION SITE PRURITUS (Injection site pruritus), INJECTION SITE SWELLING (Injection site swelling) and INJECTION SITE ERYTHEMA (injectio site redness). At the time of the report, PERIPHERAL SWELLING (swollen arm), RASH (red and itchy arm), INJECTION SITE PRURITUS (Injection site pruritus), INJECTION SITE SWELLING (Injection site swelling) and INJECTION SITE ERYTHEMA (injectio site redness) outcome was unknown.            No concomitant and treatment medication were reported.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: TCR uploaded requested call back number updated
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Amenorrhoea
Clinical narrative: Absence of period; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 03-Mar-2021 and was forwarded to Moderna on 04-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of AMENORRHOEA (Absence of period) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced AMENORRHOEA (Absence of period). At the time of the report, AMENORRHOEA (Absence of period) had not resolved.            Concomitant medications were not reported. Reportedly, the patient was not pregnant as she took a pregnancy test. Treatment details were not reported.   This case was linked to MOD-2021-062142 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal discomfort, Pain in jaw, Paraesthesia
Clinical narrative: pain in jaw; sensation of the vaccine go up my neck; TINGLING IN CHIN; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of PAIN IN JAW (pain in jaw), MUSCULOSKELETAL DISCOMFORT (sensation of the vaccine go up my neck) and PARAESTHESIA (TINGLING IN CHIN) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Bone graft.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced PAIN IN JAW (pain in jaw), MUSCULOSKELETAL DISCOMFORT (sensation of the vaccine go up my neck) and PARAESTHESIA (TINGLING IN CHIN). At the time of the report, PAIN IN JAW (pain in jaw), MUSCULOSKELETAL DISCOMFORT (sensation of the vaccine go up my neck) and PARAESTHESIA (TINGLING IN CHIN) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: No specific follow-up information recorded.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea for a month; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea for a month) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea for a month). At the time of the report, DIARRHOEA (Diarrhea for a month) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: event verbatim updated to diarrhea (earlier was 'side effect'), also reporter's email ID added
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Pain in extremity
Clinical narrative: severe pain in my right leg; could not walk; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021 and was forwarded to Moderna on 05-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (severe pain in my right leg) and GAIT DISTURBANCE (could not walk) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  The patient's past medical history included No adverse event (No medical history reported). Concomitant products included MELOXICAM for an unknown indication.    On 03-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (severe pain in my right leg) and GAIT DISTURBANCE (could not walk). At the time of the report, PAIN IN EXTREMITY (severe pain in my right leg) and GAIT DISTURBANCE (could not walk) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details were not provided
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Myalgia, Nausea, Peripheral swelling, Pyrexia
Clinical narrative: nausea; vomiting; fever had returned; struggled with body aches/pain; mild fever; swollen left arm; red left arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen left arm), ERYTHEMA (red left arm), MYALGIA (struggled with body aches/pain), NAUSEA (nausea) and VOMITING (vomiting) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Seasonal allergy. Concurrent medical conditions included Drug allergy (Medication allergies reported as sulfa, Effexor, Lexapro and Lyrica.), Autoimmune disorder, Fibromyalgia, Asthma, Chronic fatigue syndrome and Chronic migraine. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT), MONTELUKAST SODIUM (SINGULAIR), SALBUTAMOL SULFATE (PROAIR [SALBUTAMOL SULFATE]), VITAMIN D NOS, VITAMINS NOS (DAILY VITAMINS) and GABAPENTIN for an unknown indication.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 06-Feb-2021, the patient experienced PERIPHERAL SWELLING (swollen left arm) and ERYTHEMA (red left arm). On 07-Feb-2021, the patient experienced PYREXIA (mild fever). On 10-Feb-2021, the patient experienced MYALGIA (struggled with body aches/pain). On 11-Feb-2021, the patient experienced NAUSEA (nausea), VOMITING (vomiting) and PYREXIA (fever had returned). On 09-Feb-2021, PYREXIA (mild fever) had resolved. At the time of the report, PERIPHERAL SWELLING (swollen left arm), ERYTHEMA (red left arm), MYALGIA (struggled with body aches/pain), NAUSEA (nausea), VOMITING (vomiting) and PYREXIA (fever had returned) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported. On 07-Feb-2021, swollen red left arm was a lot worse. The patient had not reported the events to a HCP.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: nausea; vomiting; fever had returned; struggled with body aches/pain; mild fever; swollen left arm; red left arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen left arm), ERYTHEMA (red left arm), MYALGIA (struggled with body aches/pain), NAUSEA (nausea) and VOMITING (vomiting) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Seasonal allergy. Concurrent medical conditions included Drug allergy (Medication allergies reported as sulfa, Effexor, Lexapro and Lyrica.), Autoimmune disorder, Fibromyalgia, Asthma, Chronic fatigue syndrome and Chronic migraine. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT), MONTELUKAST SODIUM (SINGULAIR), SALBUTAMOL SULFATE (PROAIR [SALBUTAMOL SULFATE]), VITAMIN D NOS, VITAMINS NOS (DAILY VITAMINS) and GABAPENTIN for an unknown indication.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 06-Feb-2021, the patient experienced PERIPHERAL SWELLING (swollen left arm) and ERYTHEMA (red left arm). On 07-Feb-2021, the patient experienced PYREXIA (mild fever). On 10-Feb-2021, the patient experienced MYALGIA (struggled with body aches/pain). On 11-Feb-2021, the patient experienced NAUSEA (nausea), VOMITING (vomiting) and PYREXIA (fever had returned). On 09-Feb-2021, PYREXIA (mild fever) had resolved. At the time of the report, PERIPHERAL SWELLING (swollen left arm), ERYTHEMA (red left arm), MYALGIA (struggled with body aches/pain), NAUSEA (nausea), VOMITING (vomiting) and PYREXIA (fever had returned) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported. On 07-Feb-2021, swollen red left arm was a lot worse. The patient had not reported the events to a HCP.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia, Vaccination site pruritus, Vaccination site rash
Clinical narrative: vomiting; nausea; muscle pain; fever; swollen up around the injection site; rash; itching; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (vomiting), NAUSEA (nausea), MYALGIA (muscle pain), PYREXIA (fever) and VACCINATION SITE SWELLING (swollen up around the injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced VACCINATION SITE SWELLING (swollen up around the injection site), VACCINATION SITE RASH (rash) and VACCINATION SITE PRURITUS (itching). On an unknown date, the patient experienced VOMITING (vomiting), NAUSEA (nausea), MYALGIA (muscle pain) and PYREXIA (fever). At the time of the report, VOMITING (vomiting), NAUSEA (nausea), MYALGIA (muscle pain), PYREXIA (fever), VACCINATION SITE SWELLING (swollen up around the injection site), VACCINATION SITE RASH (rash) and VACCINATION SITE PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. The treatment medication was unknown.   This case was linked to MOD-2021-121591 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: Follow-up received on 09-05-2021:TCR Contain No newinformation
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vomiting
Clinical narrative: vomiting; nausea; muscle pain; fever; swollen up around the injection site; rash; itching; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (vomiting), NAUSEA (nausea), MYALGIA (muscle pain), PYREXIA (fever) and VACCINATION SITE SWELLING (swollen up around the injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced VACCINATION SITE SWELLING (swollen up around the injection site), VACCINATION SITE RASH (rash) and VACCINATION SITE PRURITUS (itching). On an unknown date, the patient experienced VOMITING (vomiting), NAUSEA (nausea), MYALGIA (muscle pain) and PYREXIA (fever). At the time of the report, VOMITING (vomiting), NAUSEA (nausea), MYALGIA (muscle pain), PYREXIA (fever), VACCINATION SITE SWELLING (swollen up around the injection site), VACCINATION SITE RASH (rash) and VACCINATION SITE PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. The treatment medication was unknown.   This case was linked to MOD-2021-121591 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: Follow-up received on 09-05-2021:TCR Contain No newinformation
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria, Vaccination site reaction
Clinical narrative: got the COVID arm with a very big welt on her left arm; got the COVID arm with a very big welt on her left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (got the COVID arm with a very big welt on her left arm) and URTICARIA (got the COVID arm with a very big welt on her left arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (got the COVID arm with a very big welt on her left arm) and URTICARIA (got the COVID arm with a very big welt on her left arm). At the time of the report, VACCINATION SITE REACTION (got the COVID arm with a very big welt on her left arm) and URTICARIA (got the COVID arm with a very big welt on her left arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported. The patient did not use any treatment medication. It was reported that it started a week or 10 days after vaccination. The patient was due for her second shot on 16-Feb-2021.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Pruritus, Type IV hypersensitivity reaction
Clinical narrative: arm was itchy; injection site was a red big circle the size of a softball; had the "Covid arm"; This spontaneous case was reported by a consumer and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION (had the "Covid arm"), PRURITUS (arm was itchy) and INJECTION SITE ERYTHEMA (injection site was a red big circle the size of a softball) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy and Bee sting hypersensitivity. Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced PRURITUS (arm was itchy) and INJECTION SITE ERYTHEMA (injection site was a red big circle the size of a softball). On an unknown date, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (had the "Covid arm"). At the time of the report, TYPE IV HYPERSENSITIVITY REACTION (had the "Covid arm"), PRURITUS (arm was itchy) and INJECTION SITE ERYTHEMA (injection site was a red big circle the size of a softball) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The treatment history was not reported.   This case was linked to MOD-2021-117516 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Patient demographic details, Past medical history, 2nd dose information, Concomitant medication details, Outcome of the event updated. On 25-Jun-2021: Follow-up received on 25-Jun-2021 and does not contain any new information
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypersomnia
Clinical narrative: sleeping a lot/slept 12 hours; tired/wiped out/dragging around; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (sleeping a lot/slept 12 hours) and FATIGUE (tired/wiped out/dragging around) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) and BUSPIRONE HYDROCHLORIDE (BUSPAR) for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced HYPERSOMNIA (sleeping a lot/slept 12 hours) and FATIGUE (tired/wiped out/dragging around). At the time of the report, HYPERSOMNIA (sleeping a lot/slept 12 hours) and FATIGUE (tired/wiped out/dragging around) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatments were reported.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Erythema, Fatigue, Feeling of body temperature change, Headache
Clinical narrative: Red (Size of a Lemon); Itchy Injection Site; Swollen Injection Site; Headache; Tired & weak; Pain on the Injection Site/ Tender to the touch Injection Site; Hot Body but Very Cold Feet and Hands; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of FEELING OF BODY TEMPERATURE CHANGE (Hot Body but Very Cold Feet and Hands), DIZZINESS (dizziness), ERYTHEMA (Red (Size of a Lemon)), HEADACHE (Headache) and FATIGUE (Tired & weak) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced FEELING OF BODY TEMPERATURE CHANGE (Hot Body but Very Cold Feet and Hands), DIZZINESS (dizziness), FATIGUE (Tired & weak) and INJECTION SITE PAIN (Pain on the Injection Site/ Tender to the touch Injection Site). On 04-Feb-2021, the patient experienced HEADACHE (Headache). On 11-Feb-2021, the patient experienced ERYTHEMA (Red (Size of a Lemon)), INJECTION SITE PRURITUS (Itchy Injection Site) and INJECTION SITE SWELLING (Swollen Injection Site). At the time of the report, FEELING OF BODY TEMPERATURE CHANGE (Hot Body but Very Cold Feet and Hands), DIZZINESS (dizziness), ERYTHEMA (Red (Size of a Lemon)), HEADACHE (Headache), FATIGUE (Tired & weak), INJECTION SITE PAIN (Pain on the Injection Site/ Tender to the touch Injection Site), INJECTION SITE PRURITUS (Itchy Injection Site) and INJECTION SITE SWELLING (Swollen Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Red (Size of a Lemon); Itchy Injection Site; Swollen Injection Site; Headache; Tired & weak; Pain on the Injection Site/ Tender to the touch Injection Site; Hot Body but Very Cold Feet and Hands; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of FEELING OF BODY TEMPERATURE CHANGE (Hot Body but Very Cold Feet and Hands), DIZZINESS (dizziness), ERYTHEMA (Red (Size of a Lemon)), HEADACHE (Headache) and FATIGUE (Tired & weak) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced FEELING OF BODY TEMPERATURE CHANGE (Hot Body but Very Cold Feet and Hands), DIZZINESS (dizziness), FATIGUE (Tired & weak) and INJECTION SITE PAIN (Pain on the Injection Site/ Tender to the touch Injection Site). On 04-Feb-2021, the patient experienced HEADACHE (Headache). On 11-Feb-2021, the patient experienced ERYTHEMA (Red (Size of a Lemon)), INJECTION SITE PRURITUS (Itchy Injection Site) and INJECTION SITE SWELLING (Swollen Injection Site). At the time of the report, FEELING OF BODY TEMPERATURE CHANGE (Hot Body but Very Cold Feet and Hands), DIZZINESS (dizziness), ERYTHEMA (Red (Size of a Lemon)), HEADACHE (Headache), FATIGUE (Tired & weak), INJECTION SITE PAIN (Pain on the Injection Site/ Tender to the touch Injection Site), INJECTION SITE PRURITUS (Itchy Injection Site) and INJECTION SITE SWELLING (Swollen Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Vaccination site rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Vaccination site rash) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Medical history was not reported.).    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE RASH (Vaccination site rash). At the time of the report, VACCINATION SITE RASH (Vaccination site rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment includes Benadryl only one pill.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Vomiting
Clinical narrative: nausea; vomiting; body aches; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), VOMITING (vomiting) and MYALGIA (body aches) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced NAUSEA (nausea), VOMITING (vomiting) and MYALGIA (body aches). At the time of the report, NAUSEA (nausea), VOMITING (vomiting) and MYALGIA (body aches) outcome was unknown. Not Provided          No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Vaccination site rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Vaccination site rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (Vaccination site rash). At the time of the report, VACCINATION SITE RASH (Vaccination site rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medication was not provided. Treatment information not provided   Reporter did not allow further contact
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Nasal congestion, Swelling face
Clinical narrative: under bottom lip puffy; congestion; cheeks puffy; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (under bottom lip puffy), NASAL CONGESTION (congestion) and SWELLING FACE (cheeks puffy) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergic reaction to drug and Allergic reaction to drug.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced LIP SWELLING (under bottom lip puffy), NASAL CONGESTION (congestion) and SWELLING FACE (cheeks puffy). At the time of the report, LIP SWELLING (under bottom lip puffy), NASAL CONGESTION (congestion) and SWELLING FACE (cheeks puffy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        Treatment details included children's Benadryl.
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Tremor
Clinical narrative: achy all over; shaking badly; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shaking badly) and MYALGIA (achy all over) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On 09-Feb-2021, the patient experienced TREMOR (shaking badly). On 10-Feb-2021, the patient experienced MYALGIA (achy all over). On 09-Feb-2021, TREMOR (shaking badly) had resolved. On 10-Feb-2021, MYALGIA (achy all over) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was unknown.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: tenderness at the injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (tenderness at the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported adverse event).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE PAIN (tenderness at the injection site). At the time of the report, VACCINATION SITE PAIN (tenderness at the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.